logo-loader
Netscientific PLC

NetScientific’s Wanda enhances Patient Management Platform with patient adherence features

The AIM-listed firm said the use of Wanda’s existing platform had been shown to predict 90% of patient-level adverse events up to seven days in advance of their occurrence and allows for virtual intervention to prevent such events

NetScientific
The alerts can be pre-scheduled and delivered via multi-modal communications

NetScientific PLC (LON:NSCI) has announced that its portfolio company Wanda Technology Enhancements has completed a significant enhancement of its Patient Management Platform to improve patient adherence to care plans.  

The AIM-listed firm said the use of Wanda’s existing platform had been shown to predict 90% of patient-level adverse events up to seven days in advance of their occurrence and allows for virtual intervention to prevent such events.

READ:NetScientific portfolio company Vortex Biosciences appoints new chief executive officer

The healthcare IP commercialisation group said the new enhanced Patient Reminder Suite empowers clinicians to better engage patients in care plan adherence through personalised reminders and alerts. These alerts can be pre-scheduled and delivered via multi-modal communications.

NetScientific said the enhancements also include the adoption of the cloud Text-to-Speech Application Programming Interface from Google that uses machine learning to deliver natural-sounding human voice automation.

Francois R. Martelet, NetScientific's chief executive officer and chairman of Wanda, said: "Wanda's enhancements to its core technology mean that relationships between clinicians and patients will continue to improve, and will empower patients to take a more active role in the management of their diseases as well as increase their quality of life.”

He added: “We continue to see invaluable potential in Wanda and look forward to monitoring its progress in the coming months."

Quick facts: Netscientific PLC

Price: £0.06

Market: AIM
Market Cap: £4.91 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Netscientific PLC named herein, including the promotion by the Company of Netscientific PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Netscientific PLC raises £5mln to speed up portfolio commercialisation

Francois Martelet, chief executive of Netscientific PLC (LON:NSCI), caught up with Proactive's Andrew Scott following the close of their £5mln fundraise. Netscientific has a core portfolio of five companies and will use the additional funding to accelerate either the float or sale of one...

on 12/4/18

2 min read